insights_auto
Outlook: 82.3% bullish·5.9% bearish
Go to analysischevron_right
TGTX:NASDAQ
TG Therapeutics Inc common stock
$64.51
arrow_downward
-0.08%(-0.050) 1D
Nov 13, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TGTX...
Open
$64.40
High
$64.96
Low
$63.38
Mkt. cap
9.75B
Avg. vol.
1.93M
Volume
1.10M
P/E ratio
95.81
52-wk high
$68.03
52-wk low
$26.76
EPS
$0.67
Beta
1.89
Shares outstanding
151.15M
No. of employees
399
Open
$64.40
High
$64.96
Low
$63.38
Mkt. cap
9.75B
Avg. vol.
1.93M
Volume
1.10M
P/E ratio
95.81
52-wk high
$68.03
52-wk low
$26.76
EPS
$0.67
Beta
1.89
Shares outstanding
151.15M
No. of employees
399
News stories
From web sources and news partners
The Motley Fool
·
1 hour ago
Prediction: This Small-Cap Value ETF Will Beat the S&P 500 Over the Next 10 Years
CNBC
·
1 day ago
Nasdaq Composite slides as Nvidia shares tumble on Jensen Huang’s exit; oil prices jump
Yahoo Finance
·
1 day ago
Stock market today: Dow, S&P 500, Nasdaq futures edge higher after wholesale inflation grows, Nvidia stock rebounds
TradingView
·
48 minutes ago
Innovative Immunology Biotech Windward Bio Lists on Nasdaq
About TG Therapeutics Inc common stock
CEOMichael S Weiss
Employees399
Founded1993
HeadquartersMorrisville, North Carolina, United States
SectorHealth Care
IndustryBiotechnology
Websitetgtherapeutics.com